Blueprint Medicines (BPMC) PT Raised to $46 at Barclays
Tweet
Share
E-mailGet Alerts BPMC Hot Sheet
Price: $129.46 --0%
Rating Summary:
11 Buy, 18 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 3 | Down: 5 | New: 34
Rating Summary:
11 Buy, 18 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 3 | Down: 5 | New: 34
Join SI Premium – FREE
Barclays analyst Peter Lawson raised the price target on Blueprint Medicines (NASDAQ: BPMC) to $46.00 (from $44.00) while maintaining a Equalweight rating.
You May Also Be Interested In
- Oracle (ORCL) PT Raised to $250 at UBS Following Q1 Results
- Sembcorp Industries (SCI:SP) PT Lowered to SGD6.39 at Macquarie
- Bank Central Asia Tbk (BBCA:IJ) (PBCRY) PT Raised to INR7,630 at Macquarie
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
